|
Evoq Remedies Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
7.94 Cr.
|
P/BV
|
0.18
|
Book Value (Rs.)
|
17.89
|
|
52 Week High/Low (Rs.)
|
12/2
|
FV/ML
|
10/4000
|
P/E(X)
|
91.14
|
|
Bookclosure
|
28/09/2024
|
EPS (Rs.)
|
0.04
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.04 | 0.03 | 1.19 | 1.09 | 10.05 |
| Diluted EPS (Rs.) | 0.04 | 0.03 | 1.19 | 1.09 | 10.05 |
| Cash EPS (Rs.) | 0.05 | 0.33 | 1.19 | 0.80 | 713.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 17.89 | 18.56 | 18.22 | 17.03 | 736.40 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 17.89 | 18.56 | 18.22 | 17.03 | 736.40 |
| Revenue From Operations / Share (Rs.) | 4.72 | 2.98 | 14.99 | 12.34 | 10024.80 |
| PBDIT / Share (Rs.) | 0.07 | 0.45 | 1.68 | 1.08 | 953.90 |
| PBIT / Share (Rs.) | 0.05 | 0.44 | 1.68 | 1.08 | 953.90 |
| PBT / Share (Rs.) | 0.05 | 0.44 | 1.68 | 1.07 | 953.90 |
| Net Profit / Share (Rs.) | 0.03 | 0.33 | 1.19 | 0.80 | 713.80 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 1.50 | 15.26 | 11.22 | 8.71 | 9.51 |
| PBIT Margin (%) | 1.09 | 15.08 | 11.21 | 8.71 | 9.51 |
| PBT Margin (%) | 1.09 | 15.08 | 11.20 | 8.68 | 9.51 |
| Net Profit Margin (%) | 0.75 | 11.16 | 7.94 | 6.50 | 7.12 |
| Return on Networth / Equity (%) | 0.19 | 1.79 | 6.53 | 4.71 | 96.93 |
| Return on Capital Employeed (%) | 0.28 | 2.42 | 9.22 | 6.31 | 128.45 |
| Return On Assets (%) | 0.17 | 1.22 | 4.64 | 3.27 | 8.87 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.00 | 0.16 | 0.38 | 0.35 | 0.01 |
| Asset Turnover Ratio (%) | 0.27 | 0.11 | 0.59 | 0.81 | 1.46 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 9.10 | 3.17 | 3.45 | 3.28 | 1.10 |
| Quick Ratio (X) | 8.69 | 2.90 | 3.25 | 3.20 | 1.08 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.00 | 0.00 | 1761.31 | 316.78 | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 | 0.00 | 1246.62 | 237.30 | 0.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 6.16 | 15.91 | 27.09 | 35.80 | 0.00 |
| EV / Net Operating Revenue (X) | 0.52 | 3.92 | 1.33 | 2.13 | 0.00 |
| EV / EBITDA (X) | 34.78 | 25.71 | 11.83 | 24.47 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.54 | 2.91 | 0.86 | 1.83 | 0.00 |
| Price / BV (X) | 0.14 | 0.46 | 0.71 | 1.33 | 0.00 |
| Price / Net Operating Revenue (X) | 0.54 | 2.91 | 0.86 | 1.83 | 0.00 |
| EarningsYield | 0.01 | 0.03 | 0.09 | 0.03 | 0.00 |
